FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113914309> ?p ?o ?g. }

• W2113914309 endingPage "9143" @default.
• W2113914309 startingPage "9139" @default.
• W2113914309 abstract "I want to ride my azacycle: The title reaction of enynamides affords a wide diversity of azacycles. The reactions are high-yielding, highly stereoselective, and proceed rapidly under mild reaction conditions. Equivalent transformations using enynhydrazides offer new routes to pyrazole and indazole scaffolds. Boc=tert-butoxycarbonyl, EWG=electron-withdrawing group, Ns=4-nitrobenzenesulfonyl, Ts=4-toluenesulfonyl. Cycloisomerizations are amongst the most atom-economical methods to access valuable organic ring systems from simple acyclic starting materials.1 1,n-Enynes have been particularly explored as cycloisomerization substrates, thus giving rise to a broad spectrum of products depending on the choice of catalyst and substrate. In contrast, reports of 1,n-enynamide cycloisomerization are limited to π-acid activation of the ynamide2 or enynamide ring-closing metathesis.3 This is surprising given the importance of azacycles in organic and medicinal chemistry, to which enynamide cycloisomerization could provide a unique and sustainable entry. Our group has established a program of research on the formation of azacycles from ynamides,4, 5 including palladium-catalyzed cyclization of bromoenynamides to amidodienes (1→2; Scheme 1), which are precursors to azabicycles 3 through Diels–Alder reactions.4b We realized that not only could we improve the atom economy of the synthesis of 2 through cycloisomerization of an enynamide 4, but also that a far greater diversity of azacyclic products might be obtained. Here we describe the first examples of palladium-catalyzed enynamide cycloisomerization, together with contrasting ruthenium-catalyzed processes. The structural outcome of these high yielding reactions depends crucially on both the catalyst6 and substrate substitution pattern. Cyclizations of enynamides to 2-amidodienes. Ts=4-toluenesulfonyl. With the elegant studies from Trost et al. on palladium-catalyzed 1,n-enyne cycloisomerization in mind,7 we began by evaluating the cyclization of the enynamide 4 a with various palladium catalysts (Table 1). To our delight, the combination of Pd(OAc)2 with either N,N′-bis(benzylidene) ethylenediamine (bbeda) or triphenylphosphine effected rapid cycloisomerization to the desired 1,3-dienamide 5 a (entries 1 and 2). In contrast, use of the bulkier ligand, P(o-tol)3, or phosphine-free conditions, led to sluggish reactions and the formation of small amounts of the enol acetate 6 a (entries 3 and 4).5c Interestingly, the use of Trost’s alternative reaction conditions for the generation of a palladium(II) hydride species ([Pd2dba3]/AcOH)7c proved effective only in the presence of bbeda (entries 5–7). [Cp*Ru(cod)Cl] has also been reported to catalyze the formation of 1,3-dienes from 1,n-enynes,1c, 8 and we were pleased to find that this catalyst was similarly competent in the formation of 5 a, albeit requiring an extended reaction time (entry 8). Entry Catalyst system t 5 a/4 a/6 a[b] 1 Pd(OAc)2/bbeda 10 min 100:0:0 2 [Pd(OAc)2(PPh3)2] 10 min 98:0:2 3 [Pd(OAc)2{P(o-tol)3}2] 1 h 31:62:7 4 Pd(OAc)2 1 h 66:29:4 5 [Pd2dba3]⋅CHCl3/AcOH 1 h 50:44:6 6 [Pd2dba3]⋅CHCl3/AcOH/bbeda 10 min 99:0:1 7 [Pd2dba3]⋅CHCl3/AcOH/P(o-tol3) 1 h 19:69:11 8 [Cp*Ru(cod)Cl][c] 1.5 h 100:0:0 With optimized reaction conditions in hand for the formation of cyclic 1,3-dienamides, we set about exploring the reaction scope (Figure 1). Alkyl-substituted 1,6-enynamides rapidly delivered the pyrrolidine enamides 5 a and 5 b in excellent yield with just 2.5 mol % catalyst, whilst aryl- and silyl-substituted ynamides required a slightly higher catalyst loading (5 mol %) to achieve complete conversion. Notably, the formation of 5 a could be performed in excellent yield on gram scale with just 1 mol % of the catalyst (83 %), and the nature of the nitrogen electron-withdrawing group could also be varied to afford the nosyl- and Boc-protected amidodienes, 5 e and 5 f, respectively. The presence of a substituent adjacent to the sulfonamide was well-tolerated (5 g), and high yields were also obtained for the formation of the piperidine enamides 5 h–k from 1,7-enynamides. In all cases, the reactions proved highly stereoselective, with only trace amounts of the isomeric E enamides being observed (Z/E=97:3).9 Cycloisomerization of monosubstituted enynamides to 1,3-dienes and bicyclic cyclobutenes. [a] Figures in parentheses indicate reaction time. Yields are those of isolated products. Products isolated as a 97:3 Z/E ratio of enamides as determined by 1H NMR spectroscopic analysis of the crude reaction mixture.9 [b] Performed on 1 g scale with 1 mol % catalyst (2.5 h). [c] Performed using 5 mol % catalyst. [d] Performed using 10 mol % catalyst. [e] Isolated as a 92:8 Z/E ratio of enamides. [f] Figures in parentheses indicate reaction temperature/time. Yields are those of isolated products. Ns=4-O2NC6H4SO2, Boc=tert-butoxycarbonyl, TBS=tert-butyldimethylsilyl. Alkyl-substituted 1,6-enynamides were also viable substrates under ruthenium catalysis (Figure 1), which afforded the pyrrolidine enamides 5 a and 5 b as single isomers in high yield. However, a remarkable switch in reaction outcome was seen on examining 1,7-enynamides, with the 6,4-fused cyclobutenes 7 a–c being formed in excellent yields with only trace amounts of the corresponding 1,3-dienes (<5 %).10, 11 It is notable that formal [2+2] cycloadditions of ynamides usually require either electron-deficient or strained-alkene coupling partners, whereas in this intramolecular case high efficiency is observed with unstrained, electron-neutral alkenes.12 Indeed for 7 c, this cycloisomerization occurred rapidly at room temperature, presumably due to a beneficial Thorpe–Ingold effect. We next turned our attention to enynamides featuring 1,2-disubstituted alkenes, which have the potential to form either 1,3- or 1,4-dienes (Table 2). The cycloisomerization of enynamides with an ethyl-substituted E alkene (entries 1 and 2) successfully gave the E-1,4-dienes (E)-8 a and (E)-8 b as the major products, along with moderate amounts of the 1,3-diene. The analogous Z-alkene substrates 4 n and 4 o proved more reactive, and also favored formation of (E)-8 a and (E)-8 b, now to the exclusion of 1,3-diene, but with minor amounts of the Z-1,4-diene (entries 3 and 4). The regio- and stereoselectivity of these processes likely reflects the relative ease of β-hydride elimination from probable alkylpalladium(II) intermediates (see Scheme 3). The styrenyl ynamides 4 p and 4 q, which lack the hydrogen atoms required for 1,4-diene formation, pleasingly afforded the 1,3-dienes (E)-5 l and (Z)-5 l, respectively, as single stereoisomers (entries 5 and 6), further supporting the involvement of a stereospecific β-hydride elimination step. To enhance selectivity for the formation of the 1,3-diene from alkyl-substituted alkenes, we examined the cycloisomerization of allylic silyl ether 4 r (entry 7), a tactic successfully employed by Trost.13 We found that this indeed improved selectivity for the 1,3-diene (E)-5 m, which for convenience was isolated as the free alcohol after treatment with TBAF. A piperidine 1,4-dienamide could also be prepared by cycloisomerization of the 1,7-enynamide 4 s (entry 8). Finally, we were intrigued to study the potential for diastereoselective cycloisomerization. To our delight, the cyclization of the α-branched enynamides 4 t and 4 u gave the 1,4-dienes (E)-8 d and (E)-8 e, respectively, as single diastereomers (entries 9 and 10).9 In the case of (E)-8 e, minor amounts of 1,3-diene and a 1,5-diene arising from palladium-catalyzed alkene isomerization,14 were also observed. This relay of stereochemistry for these substrates represents the first example of diastereoselective ynamide cycloisomerizations, and augurs well for the stereocontrolled synthesis of polysubstituted azacycles such as indolizidine and quinolizidine alkaloids.15 Entry Subs- trate n R1 R2 R3 T t Major product Yield[b] 5/(E)-8/(Z)-8[c] 1 4 l 1 Hex H (E)-Et 60 °C 30 min 80 % 22:78:0 2 4 m 1 Ph H (E)-Et 60 °C 30 min 83 % 27:70:3 3 4 n 1 Hex H (Z)-Et 25 °C 1.5 h 87 % 0:86:14 4 4 o 1 Ph H (Z)-Et 60 °C 30 min 81 % 0:91:9 5 4 p 1 Hex H (E)-Ph 60 °C 4 h 82 % –[d] 6 4 q 1 Hex H (Z)-Ph 60 °C 20 min 84 % –[d] 7 4 r 1 Hex H (Z)-CH2OTBS 60 °C 20 min[e] 53 %[f] 66:17:17 8 4 s 2 Hex H (Z)-Me 60 °C 20 min[e] 72 % 9:91 9 4 t 1 Hex Ph (Z)-nPr 25 °C 3 h 87 % 0:100:0 10 4 u 2 Hex Bn (Z)-Et 60 °C 1.5 h 86 % 9:77:14[g] 11 4 m 1 Ph H (E)-Et 60 °C 1 h 84 % 33:9:58[h] Subjecting the disubstituted enynamides to ruthenium-catalyzed cycloisomerization conditions revealed lower reactivity. Of the substrates studied, only 4 k underwent successful cycloisomerization, intriguingly giving the (Z,Z)-1,4-diene (Z)-8 b as the major product (entry 11)—a result that supports the operation of different reaction pathways for the two catalyst systems (see below). Having established cycloisomerizations of acyclic enynamides, we next turned to cycloalkenyl ynamides which have the potential to form a range of interesting azabicycles not readily accessible through other means (Table 3).9 In the case of the cyclohexenyl ynamide 9 a, cyclization proceeded smoothly at room temperature to give the cis-fused bicycle 10 a in high yield (89 %). Pleasingly, the cycloheptenyl analogue 9 b also cyclized efficiently at room temperature, thus giving the 5,7-cis-fused azabicycle 10 b (91 %), along with a minor amount of the trans-fused diastereomer. Cyclization of the cyclohexenyl ynamide 9 c was similarly successful, giving the spirocyclic 1,4-diene 10 c (82 %).7c, 11 Lastly, reaction of enynamide 9 d led to the bridged azabicycle 10 d (77 %), a structure which bears close resemblance to the core of the alkaloid peduncularine.16 To the best of our knowledge, this represents the first example of the use of cycloisomerization to access a bridged bicyclic system. It is of some note that this methodology is able to prepare, with high efficiency, these three distinct and challenging classes of azabicycle. Entry Substrate T [°C] t [h] Major product Yield [%][b] Ratio 1 25 2.5 89 96:4[c] 2 25 2.5 91 90:10[d] 3 60 1 82 93:7[e] 4 35 5 77 91:9[c] As a final extension, we were attracted to a recent approach to ynhydrazides,17 which we found enabled a one-pot synthesis of enynhydrazides 11 a–c (Scheme 2), substrates which are unexplored in cycloisomerization, through in situ alkylation. We were delighted to find that these substrates underwent smooth cyclization at low catalyst loading (1 mol %), giving the corresponding 1,3- and 1,4-pyrazole dienes 12 a–c in excellent yields, including an attractive tetrahydroindazole framework (12 c). These products offer many possibilities for the construction of other diazacycles. For instance, treatment of 12 a with dimethylacetylene dicarboxylate afforded the complementary tetrahydroindazole 13. Notably, this cycloisomerization/cycloaddition sequence could also be carried out in a single step (56 %), thus affording these synthetically challenging systems in just two operations from commercial materials. Synthesis and cycloisomerization of enynhydrazides. a) nBuLi, THF, −78 °C; BocNNBoc; allyl bromide, 59 %. b) nBuLi, THF, −78 °C; BocNNBoc; R-Br, nBu4NI (20 mol %), nBu4NHSO4 (20 mol %), NaOH (aq.)/toluene (1:1), 78 % (11 b, R=(E)-CH2CHCHPh), 70 % (11 c, R=3-cyclohexenyl); c) Pd(OAc)2 (1 mol %), bbeda (1 mol %), toluene 60 °C, 84 %; d) MeO2CCCCO2Me, toluene, 80 °C, 62 %. e) Pd(OAc)2 (1 mol %), bbeda (1 mol %), toluene, 60 °C; then add MeO2CCCCO2Me, 80 °C, 56 %. The contrasting outcomes of these palladium- and ruthenium-catalyzed processes can be explained by two mechanistic manifolds (Scheme 3). Under palladium catalysis, an in situ generated palladium(II) hydride species effects regioselective hydropalladation of the ynamide to afford alkenylpalladium intermediate 14. Ensuing carbopalladation gives the alkylpalladium species 15, which (depending on the substrate) has a choice of hydrogen atoms with which to undergo β-hydride elimination. Loss of Ha delivers the 1,3-dienes 5, whilst elimination of Hb or Hc leads to the E- or Z-1,4-dienes 8. The highly stereoselective cyclizations of 4 t and 4 u suggest that the sulfonamide plays an important role not only as an ynamide/enamide stabilizing group, but also as a fluxional stereogenic center. The stereoselectivity (for 4 t) can be explained by conformation 16, which minimizes 1,3-allylic strain between the ynamide side chain and tosyl group, places the phenyl substituent in a pseudo-equatorial position, and orients the alkenyl side chain pseudo-axial to avoid unfavorable steric interactions with the bbeda ligand (a similar model can be used to rationalize the cyclization of 4 u). Under ruthenium catalysis, initial complexation of the catalyst to both the alkene and ynamide enables ruthenacycle formation (17). With a six-membered tether, direct reductive elimination then leads to the 6,4-fused cyclobutene product 7. However for 5,5-fused ruthenacycles, developing ring strain presumably prohibits reductive elimination, and instead β-hydride elimination affords the diene products, albeit in differing ratios to those obtained under palladium catalysis. Proposed cycloisomerization mechanisms. In conclusion, we have demonstrated that alkenyl ynamides and ynhydrazides, which are readily prepared from simple precursors, undergo high yielding cycloisomerizations under palladium and ruthenium catalysis. These operationally simple processes occur with high stereo- and regioselectivity, affording a wide diversity of attractive azacyclic scaffolds. The reactions are tolerant of a range of substituents on both the ynamide and alkene, underlining their potential utility as an atom-economical source of azacycles. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article." @default.
• W2113914309 created "2016-06-24" @default.
• W2113914309 creator A5005091286 @default.
• W2113914309 creator A5017482759 @default.
• W2113914309 creator A5038583451 @default.
• W2113914309 creator A5056981374 @default.
• W2113914309 creator A5088141048 @default.
• W2113914309 date "2013-07-15" @default.
• W2113914309 modified "2023-10-18" @default.
• W2113914309 title "Palladium- and Ruthenium-Catalyzed Cycloisomerization of Enynamides and Enynhydrazides: A Rapid Approach to Diverse Azacyclic Frameworks" @default.
• W2113914309 cites W1974525538 @default.
• W2113914309 cites W1976032996 @default.
• W2113914309 cites W1979194753 @default.
• W2113914309 cites W1981042925 @default.
• W2113914309 cites W1987098685 @default.
• W2113914309 cites W1994441213 @default.
• W2113914309 cites W1996648695 @default.
• W2113914309 cites W2002911413 @default.
• W2113914309 cites W2003905240 @default.
• W2113914309 cites W2004782192 @default.
• W2113914309 cites W2020731609 @default.
• W2113914309 cites W2034743818 @default.
• W2113914309 cites W2044579486 @default.
• W2113914309 cites W2050785738 @default.
• W2113914309 cites W2054218288 @default.
• W2113914309 cites W2054953817 @default.
• W2113914309 cites W2055905868 @default.
• W2113914309 cites W2056875757 @default.
• W2113914309 cites W2065868460 @default.
• W2113914309 cites W2071011692 @default.
• W2113914309 cites W2074719625 @default.
• W2113914309 cites W2076405539 @default.
• W2113914309 cites W2077961279 @default.
• W2113914309 cites W2091473556 @default.
• W2113914309 cites W2093663623 @default.
• W2113914309 cites W2101515332 @default.
• W2113914309 cites W2103968992 @default.
• W2113914309 cites W2107124170 @default.
• W2113914309 cites W2108686830 @default.
• W2113914309 cites W2110987389 @default.
• W2113914309 cites W2117162895 @default.
• W2113914309 cites W2134722321 @default.
• W2113914309 cites W2135084192 @default.
• W2113914309 cites W2135429826 @default.
• W2113914309 cites W2137460597 @default.
• W2113914309 cites W2138790951 @default.
• W2113914309 cites W2146089571 @default.
• W2113914309 cites W2156846886 @default.
• W2113914309 cites W2169262808 @default.
• W2113914309 cites W2172297769 @default.
• W2113914309 cites W2317128156 @default.
• W2113914309 cites W2333731992 @default.
• W2113914309 cites W2334736823 @default.
• W2113914309 cites W2949576548 @default.
• W2113914309 cites W2949635787 @default.
• W2113914309 cites W2950517020 @default.
• W2113914309 cites W2951142843 @default.
• W2113914309 cites W2951888144 @default.
• W2113914309 cites W2951940968 @default.
• W2113914309 cites W4211259730 @default.
• W2113914309 cites W4235214259 @default.
• W2113914309 cites W4239796443 @default.
• W2113914309 cites W4243745337 @default.
• W2113914309 cites W4244770675 @default.
• W2113914309 doi "https://doi.org/10.1002/anie.201304186" @default.
• W2113914309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23857937" @default.
• W2113914309 hasPublicationYear "2013" @default.
• W2113914309 type Work @default.
• W2113914309 sameAs 2113914309 @default.
• W2113914309 citedByCount "58" @default.
• W2113914309 countsByYear W21139143092014 @default.
• W2113914309 countsByYear W21139143092015 @default.
• W2113914309 countsByYear W21139143092016 @default.
• W2113914309 countsByYear W21139143092017 @default.
• W2113914309 countsByYear W21139143092018 @default.
• W2113914309 countsByYear W21139143092019 @default.
• W2113914309 countsByYear W21139143092020 @default.
• W2113914309 countsByYear W21139143092021 @default.
• W2113914309 countsByYear W21139143092022 @default.
• W2113914309 countsByYear W21139143092023 @default.
• W2113914309 crossrefType "journal-article" @default.
• W2113914309 hasAuthorship W2113914309A5005091286 @default.
• W2113914309 hasAuthorship W2113914309A5017482759 @default.
• W2113914309 hasAuthorship W2113914309A5038583451 @default.
• W2113914309 hasAuthorship W2113914309A5056981374 @default.
• W2113914309 hasAuthorship W2113914309A5088141048 @default.
• W2113914309 hasBestOaLocation W21139143091 @default.
• W2113914309 hasConcept C161790260 @default.
• W2113914309 hasConcept C171250308 @default.
• W2113914309 hasConcept C178790620 @default.
• W2113914309 hasConcept C185592680 @default.
• W2113914309 hasConcept C192562407 @default.
• W2113914309 hasConcept C21951064 @default.
• W2113914309 hasConcept C2776788722 @default.
• W2113914309 hasConcept C502130503 @default.
• W2113914309 hasConcept C555196967 @default.
• W2113914309 hasConcept C75473681 @default.
• W2113914309 hasConceptScore W2113914309C161790260 @default.

• next